Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Liquid Biopsy
|
January 16, 2026
Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analysis
Mette M Steiniche, Louise B Callesen, Elizabeth H Vlk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2019
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
J Hamfjord, T K Guren, O Dajani, et al.
The Oncologist
|
August 6, 2017
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Karen-Lise G Spindler, Anders K Boysen, Niels Pallisgård, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
February 26, 2020
Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer - A multicentre dose planning study
Ane L Appelt, Ellen M Kerkhof, Lars Nyvang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 18, 2026
Bone-sparing chemoradiotherapy for anal cancer - Results of a phase II trial by the Danish Anal Cancer Group - The DACG II (NCT05385250)
Karen-Lise G Spindler, Anne V Jakobsen, Erik M Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2025
The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST
Mette M Steiniche, Sidsel C Lindgaard, Inna M Chen, et al.
Clinical and Translational Radiation Oncology
|
July 18, 2025
Acute toxicity and quality of life in dose-escalated proton reirradiation for locally recurrent rectal cancer: The prospective ReRad II trial
C G Truelsen, H S Rønde, J F Kallehauge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 29, 2020
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
C A M Marijnen, F P Peters, C Rödel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 2, 2026
Multiplex methylation marker analysis for ctDNA detection in liquid biopsies from anal cancer patients: an HPV-independent approach
Søren Kahns, Luisa M D Canto, Laura E Stokkebro, et al.
Environmental Science and Pollution Research International
|
November 13, 2008
Abstracts of the 6th FECS Conference 1998 Lectures
F S Rowland, D R Blake, B R Larsen, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Liquid Biopsy
|
January 16, 2026
Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analysis
Mette M Steiniche, Louise B Callesen, Elizabeth H Vlk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2019
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
J Hamfjord, T K Guren, O Dajani, et al.
The Oncologist
|
August 6, 2017
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Karen-Lise G Spindler, Anders K Boysen, Niels Pallisgård, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
February 26, 2020
Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer - A multicentre dose planning study
Ane L Appelt, Ellen M Kerkhof, Lars Nyvang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 18, 2026
Bone-sparing chemoradiotherapy for anal cancer - Results of a phase II trial by the Danish Anal Cancer Group - The DACG II (NCT05385250)
Karen-Lise G Spindler, Anne V Jakobsen, Erik M Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2025
The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST
Mette M Steiniche, Sidsel C Lindgaard, Inna M Chen, et al.
Clinical and Translational Radiation Oncology
|
July 18, 2025
Acute toxicity and quality of life in dose-escalated proton reirradiation for locally recurrent rectal cancer: The prospective ReRad II trial
C G Truelsen, H S Rønde, J F Kallehauge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 29, 2020
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
C A M Marijnen, F P Peters, C Rödel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 2, 2026
Multiplex methylation marker analysis for ctDNA detection in liquid biopsies from anal cancer patients: an HPV-independent approach
Søren Kahns, Luisa M D Canto, Laura E Stokkebro, et al.
Environmental Science and Pollution Research International
|
November 13, 2008
Abstracts of the 6th FECS Conference 1998 Lectures
F S Rowland, D R Blake, B R Larsen, et al.
Page
of 5